H. B. Fuller (NYSE:FUL) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

H. B. Fuller (NYSE:FUL - Get Free Report) had its target price lifted by analysts at JPMorgan Chase & Co. from $50.00 to $54.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has an "underweight" rating on the specialty chemicals company's stock. JPMorgan Chase & Co.'s price target points to a potential downside of 14.05% from the company's previous close.

A number of other equities analysts also recently commented on the company. Baird R W upgraded H. B. Fuller from a "hold" rating to a "strong-buy" rating in a research note on Thursday, April 17th. Robert W. Baird upgraded H. B. Fuller from a "neutral" rating to an "outperform" rating and set a $60.00 price target for the company in a report on Thursday, April 17th. Finally, Seaport Res Ptn cut shares of H. B. Fuller from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. One analyst has rated the stock with a sell rating, four have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $63.50.

H. B. Fuller Trading Up 1.4%

NYSE FUL opened at $62.83 on Friday. The company has a current ratio of 1.97, a quick ratio of 1.21 and a debt-to-equity ratio of 1.23. The company's fifty day simple moving average is $55.31 and its 200-day simple moving average is $58.48. The stock has a market cap of $3.40 billion, a P/E ratio of 33.91, a PEG ratio of 0.85 and a beta of 1.12. H. B. Fuller has a 52 week low of $47.56 and a 52 week high of $87.67.

H. B. Fuller (NYSE:FUL - Get Free Report) last released its quarterly earnings results on Wednesday, June 25th. The specialty chemicals company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.10 by $0.08. H. B. Fuller had a return on equity of 11.59% and a net margin of 2.92%. The business had revenue of $898.10 million for the quarter, compared to analysts' expectations of $894.87 million. During the same quarter in the previous year, the firm posted $1.12 earnings per share. The company's revenue was down 2.1% compared to the same quarter last year. Equities research analysts predict that H. B. Fuller will post 4.07 EPS for the current fiscal year.

Insider Activity

In other H. B. Fuller news, CEO Celeste Beeks Mastin acquired 3,500 shares of the firm's stock in a transaction on Tuesday, April 1st. The stock was purchased at an average cost of $56.66 per share, for a total transaction of $198,310.00. Following the transaction, the chief executive officer now owns 3,500 shares of the company's stock, valued at $198,310. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.99% of the company's stock.

Hedge Funds Weigh In On H. B. Fuller

A number of large investors have recently made changes to their positions in FUL. Amundi grew its position in H. B. Fuller by 191.9% during the fourth quarter. Amundi now owns 28,553 shares of the specialty chemicals company's stock valued at $1,804,000 after purchasing an additional 18,771 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of H. B. Fuller by 17.2% in the fourth quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company's stock worth $37,448,000 after acquiring an additional 81,558 shares during the last quarter. Kennedy Capital Management LLC raised its holdings in shares of H. B. Fuller by 13.4% during the fourth quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company's stock worth $8,630,000 after acquiring an additional 15,100 shares in the last quarter. New Age Alpha Advisors LLC acquired a new stake in H. B. Fuller during the fourth quarter valued at $465,000. Finally, Jones Financial Companies Lllp boosted its position in H. B. Fuller by 128.8% during the fourth quarter. Jones Financial Companies Lllp now owns 899 shares of the specialty chemicals company's stock valued at $61,000 after purchasing an additional 506 shares during the last quarter. Institutional investors and hedge funds own 95.93% of the company's stock.

H. B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.